PT3611158T - Derivado de 1,3-di-oxo-indeno, seu sal farmaceuticamente aceitável ou isómero ótico, seu método de preparação, e composição farmacêutica contendo o mesmo como ingrediente ativo, antiviral - Google Patents

Derivado de 1,3-di-oxo-indeno, seu sal farmaceuticamente aceitável ou isómero ótico, seu método de preparação, e composição farmacêutica contendo o mesmo como ingrediente ativo, antiviral

Info

Publication number: PT3611158T
Authority: PT; Portugal
Prior art keywords: antiviral; oxo; preparation; pharmaceutically acceptable; pharmaceutical composition
Prior art date: 2011-06-16

Application number

PT191795467T

Other languages

English (en)

Portuguese (pt)

Original Assignee

Univ Leuven Kath

Korea Res Inst Chemical Tech

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-06-16

Filing date

2012-06-18

Publication date

2024-03-22

2012-06-18 Application filed by Univ Leuven Kath, Korea Res Inst Chemical Tech filed Critical Univ Leuven Kath

2024-03-22 Publication of PT3611158T publication Critical patent/PT3611158T/pt

Links

UHKAJLSKXBADFT-UHFFFAOYSA-N 1,3-indandione Chemical class C1=CC=C2C(=O)CC(=O)C2=C1 UHKAJLSKXBADFT-UHFFFAOYSA-N 0.000 title 1
239000004480 active ingredient Substances 0.000 title 1
230000000840 anti-viral effect Effects 0.000 title 1
230000003287 optical effect Effects 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
238000002360 preparation method Methods 0.000 title 1
150000003839 salts Chemical class 0.000 title 1

PT191795467T 2011-06-16 2012-06-18 Derivado de 1,3-di-oxo-indeno, seu sal farmaceuticamente aceitável ou isómero ótico, seu método de preparação, e composição farmacêutica contendo o mesmo como ingrediente ativo, antiviral PT3611158T (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
KR20110058704		2011-06-16

Publications (1)

Publication Number	Publication Date
PT3611158T true PT3611158T (pt)	2024-03-22

Family

ID=90469768

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT191795467T PT3611158T (pt)	2011-06-16	2012-06-18	Derivado de 1,3-di-oxo-indeno, seu sal farmaceuticamente aceitável ou isómero ótico, seu método de preparação, e composição farmacêutica contendo o mesmo como ingrediente ativo, antiviral

Country Status (4)

Country	Link
ES (1)	ES2974025T3 (pl)
PL (1)	PL3611158T3 (pl)
PT (1)	PT3611158T (pl)
SI (1)	SI3611158T1 (pl)

2012
- 2012-06-18 SI SI201232059T patent/SI3611158T1/sl unknown
- 2012-06-18 PL PL19179546.7T patent/PL3611158T3/pl unknown
- 2012-06-18 PT PT191795467T patent/PT3611158T/pt unknown
- 2012-06-18 ES ES19179546T patent/ES2974025T3/es active Active

Also Published As

Publication number	Publication date
SI3611158T1 (sl)	2024-07-31
ES2974025T3 (es)	2024-06-25
PL3611158T3 (pl)	2024-07-29

Similar Documents

Publication	Publication Date	Title
EP2522653A4 (en)	2013-06-12	BIGUANIDE DERIVATIVE, PROCESS FOR PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE BIGUANIDE DERIVATIVE AS AN ACTIVE SUBSTANCE
WO2013100566A8 (en)	2014-02-20	Phenyl alkyl carbamate derivative compound and pharmaceutical composition containing the same
LT2808325T (lt)	2018-02-12	Pakeistieji azolai, antivirusinis aktyvus ingredientas, farmacinė kompozicija, jų gavimo ir panaudojimo būdas
WO2012021715A3 (en)	2012-05-18	Stable formulations of linaclotide
ZA201300241B (en)	2014-03-26	Pharmaceutical composition comprising amide derivative or pharmaceutically acceptable salt thereof
CA3293510A1 (en)	2026-03-02	Indanone derivatives, pharmaceutically acceptable salts or optical isomers thereof, preparation method for same, and pharmaceutical compositions containing same as active ingredient for preventing or treating viral diseases
ZA201707096B (en)	2018-11-28	Heteroaryl derivative or pharmaceutically acceptable salt thereof, preparation method therefor, and pharmaceutical composition for preventing or treating diseases associated with pi3 kinases, containing same as active ingredient
IL230487B (en)	2019-06-30	6-(n-(7-chloro-1-hydroxy-3,1-dihydrobenzo[c][1,2]oxaborole-5-yl)methylsulfonamido)-5-cyclopropyl-2-(4-fluorophenyl)-n- Methylbenzofuran-3-carboxamide, their salts and pharmaceutical preparations containing them
ZA201500362B (en)	2016-01-27	Novel compound having ability to inhibit 11b-hsd1 enzyme or pharmaceutically acceptable salt thereof, method for producing same, and pharmaceutical composition containing same as active ingredient
EP2987786A4 (en)	2016-12-28	AMIDOPYRIDINOL DERIVATIVE OR PHARMACEUTICAL, SALT AND PHARMACEUTICAL COMPOSITION THEREFOR AS ACTIVE SUBSTANCE
WO2013128379A3 (en)	2013-10-31	Crystalline polymorphic forms of linagliptin
PT2722322T (pt)	2019-09-27	Derivado de 1,3-di-oxo-indeno, seu sal farmaceuticamente aceitável ou isómero ótico, seu método de preparação, e composição farmacêutica contendo o mesmo como ingrediente ativo, antiviral
PL2647637T3 (pl)	2016-06-30	Pochodna purynylopirydynyloamino-2,4-dlfluorofenylo-sulfonamidu, jej farmaceutycznie dopuszczalna sól, sposób jej wytwarzania oraz zawierająca ją jako składnik aktywny kompozycja farmaceutyczna o aktywności hamującej kinazę Raf
WO2013169746A3 (en)	2013-12-05	N-ethyl-4-hydroxyl-1-methyl-5- (methyl(2,3,4,5,6-pentahydroxyhexyl) amino) -2-oxo-n-phenyl-1,2-dihydroquinoline-3-carboxamide
EP3352750A4 (en)	2018-08-01	Cyclohexene derivative, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic disease comprising the same as active ingredient
IL230907A0 (en)	2014-03-31	Salt and formations of a pyrazolopyrimidine compound, a medical composition that includes the above, and a preparation and use process for them
PL3882244T3 (pl)	2025-06-16	ZWIĄZEK, JEGO FARMACEUTYCZNIE DOPUSZCZALNA SÓL LUB IZOMER OPTYCZNY, SPOSÓB ICH WYTWARZANIA i ZAWIERAJĄCA JE, JAKO SKŁADNIK AKTYWNY, KOMPOZYCJA FARMACEUTYCZNA DO PROFILAKTYKI LUB LECZENIA CHORÓB WIRUSOWYCH
EP3010534A4 (en)	2017-01-25	Pharmaceutical formulations and methods for oral delivery of biologically active ingredient
PT3611158T (pt)	2024-03-22	Derivado de 1,3-di-oxo-indeno, seu sal farmaceuticamente aceitável ou isómero ótico, seu método de preparação, e composição farmacêutica contendo o mesmo como ingrediente ativo, antiviral
WO2013072770A3 (en)	2013-10-24	Pharmaceutical formulations comprising atorvastatin and glimepiride
ZA201801839B (en)	2020-09-30	Pharmaceutical composition for preventing and treating liver diseases, containing, as active ingredient, cromolyn or pharmaceutically acceptable salt thereof
ZA201803722B (en)	2019-03-27	Pharmaceutical composition containing, as active ingredient, 7-azaindolin-2-one derivative or pharmaceutically acceptable salt thereof
WO2012108794A3 (ru)	2012-10-26	Производные 1,2,4-триазол-з-илтиогликолевой кислоты для применения в терапии
WO2013035997A3 (en)	2013-07-04	Pharmaceutical composition for preventing or treating alopecia comprising tianeptine or its salt
GR1008380B (el)	2014-12-18	Φαρμακευτικο σκευασμα περιεχον ενα αντιικο παραγοντα και μεθοδος για την παρασκευη αυτου